Lars Rydén

1.1k total citations
18 papers, 550 citations indexed

About

Lars Rydén is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Lars Rydén has authored 18 papers receiving a total of 550 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cardiology and Cardiovascular Medicine, 5 papers in Surgery and 3 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Lars Rydén's work include Acute Myocardial Infarction Research (5 papers), Cardiac electrophysiology and arrhythmias (4 papers) and Cardiovascular Function and Risk Factors (3 papers). Lars Rydén is often cited by papers focused on Acute Myocardial Infarction Research (5 papers), Cardiac electrophysiology and arrhythmias (4 papers) and Cardiovascular Function and Risk Factors (3 papers). Lars Rydén collaborates with scholars based in Sweden, United States and Denmark. Lars Rydén's co-authors include Åke Hjalmarson, Johan Herlitz, Ulf Stenestrand, Anna Norhammar, Lars Wallentin, Per Tornvall, Klas Malmberg, Garry Jennings, Peter Sleight and Salim Yusuf and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Lars Rydén

18 papers receiving 490 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lars Rydén Sweden 11 428 153 111 76 42 18 550
Greetje de Vries Netherlands 5 364 0.9× 132 0.9× 91 0.8× 88 1.2× 65 1.5× 5 719
I. Kardasz Italy 5 371 0.9× 104 0.7× 87 0.8× 77 1.0× 26 0.6× 6 504
C. Thuillez France 8 515 1.2× 103 0.7× 116 1.0× 39 0.5× 40 1.0× 18 685
M.L. Muiesan Italy 13 389 0.9× 111 0.7× 95 0.9× 36 0.5× 35 0.8× 41 525
Wassim Choucair United States 13 890 2.1× 86 0.6× 92 0.8× 80 1.1× 44 1.0× 14 1.1k
Francesca Palano Italy 13 475 1.1× 116 0.8× 72 0.6× 53 0.7× 59 1.4× 28 590
W. Kamke Germany 9 622 1.5× 189 1.2× 81 0.7× 56 0.7× 43 1.0× 17 759
Pieralberto Visentin Italy 10 386 0.9× 248 1.6× 180 1.6× 25 0.3× 40 1.0× 15 563
İstemi Nalbantgil Türkiye 11 238 0.6× 84 0.5× 63 0.6× 65 0.9× 16 0.4× 34 337
E. Laufer Australia 9 481 1.1× 66 0.4× 107 1.0× 80 1.1× 21 0.5× 18 586

Countries citing papers authored by Lars Rydén

Since Specialization
Citations

This map shows the geographic impact of Lars Rydén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Rydén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Rydén more than expected).

Fields of papers citing papers by Lars Rydén

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Rydén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Rydén. The network helps show where Lars Rydén may publish in the future.

Co-authorship network of co-authors of Lars Rydén

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Rydén. A scholar is included among the top collaborators of Lars Rydén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Rydén. Lars Rydén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Rydén, Lars, Eberhard Standl, Malgorzata Bartnik, et al.. (2007). [Guidelines on diabetes, pre-diabetes, and cardiovascular diseases].. SHILAP Revista de lepidopterología. 60(5). 1e–64e. 14 indexed citations
3.
Gustafsson, Finn, Klas Malmberg, Lars Rydén, et al.. (2006). [Metabolic control by means of insulin in patients with type 2 diabetes and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity--secondary publication].. PubMed. 168(6). 581–4. 1 indexed citations
4.
Norhammar, Anna, Klas Malmberg, Lars Rydén, et al.. (2003). Under utilisation of evidence-based treatment partially explains for the unfavourable prognosis in diabetic patients with acute myocardial infarction.. PubMed. 24(9). 838–44. 95 indexed citations
5.
Beller, George A. & Lars Rydén. (2000). Joint efforts across national boundaries between professional organizations in cardiovascular medicine: one way into the future. Journal of the American College of Cardiology. 36(3). 957–958. 4 indexed citations
6.
Gadler, Fredrik, Cecilia Linde, & Lars Rydén. (1999). Rapid return of left ventricular outflow tract obstruction and symptoms following cessation of long-term atrioventricular synchronous pacing for obstructive hypertrophic cardiomyopathy. The American Journal of Cardiology. 83(4). 553–557. 12 indexed citations
7.
Hatori, Nobuo, Robert L. Roberts, Hiroyuki Tadokoro, et al.. (1991). Differences in Infarct Size with Lidocaine as Compared with Bretylium Tosylate in Acute Myocardial Ischemia and Reperfusion in Pigs. Journal of Cardiovascular Pharmacology. 18(4). 581–588. 19 indexed citations
8.
Grip, Lars & Lars Rydén. (1991). Late streptokinase infusion and antithrombotic treatment in myocardial infarction reduce subsequent myocardial ischemia. American Heart Journal. 121(3). 737–745. 7 indexed citations
9.
Tadokoro, Hiroyuki, et al.. (1991). Retrograde coronary venous administration of recombinant tissue-type plasminogen activator: A unique and effective approach to coronary artery thrombolysis. Journal of the American College of Cardiology. 18(2). 613–620. 11 indexed citations
10.
Olsson, Gunnar, Bengt Åblad, & Lars Rydén. (1990). Long‐Term Cardiovascular Effects of Metoprolol Therapy: A Review Article. The Journal of Clinical Pharmacology. 30(S2). S118–23. 5 indexed citations
11.
Herlitz, Johan, et al.. (1988). Mortality and Morbidity During a Five‐year Follow‐up of Diabetics with Myocardial Infarction. Acta Medica Scandinavica. 224(1). 31–38. 125 indexed citations
12.
Herlitz, Johan, Åke Hjalmarson, Karl Swedberg, Lars Rydén, & Finn Waagstein. (1988). Effects on Mortality during Five Years after Early Intervention with Metoprolol in Suspected Acute Myocardial Infarction. Acta Medica Scandinavica. 223(3). 227–231. 12 indexed citations
13.
Herlitz, Johan, Dag Elmfeldt, Åke Hjalmarson, et al.. (1983). Effect of metoprolol on indirect signs of the size and severity of acute myocardial infarction. The American Journal of Cardiology. 51(8). 1282–1288. 72 indexed citations
14.
Larsson, Bertil, et al.. (1981). Investigation of the Mechanism of Perforation of an Intrauterine Device in Pigs and Dogs. Fertility and Sterility. 36(2). 225–228. 1 indexed citations
15.
Larsson, Bertil, et al.. (1981). The Possible Risks of a Copper and an Inert Intrauterine Device Situated in me Abdominal Cavity: an Experimental Study in Pigs and Dogs. Fertility and Sterility. 36(2). 229–231. 4 indexed citations
16.
Rydén, Lars, et al.. (1981). Metoprolol and Atenolol Administered Once Daily in Primary Hypertension. Acta Medica Scandinavica. 209(1-6). 261–266. 27 indexed citations
17.
Conradson, Thor‐Björn, et al.. (1976). The effect of intravenous digoxin on the occurrence of ventricular tachyarrhythmias in acute myocardial infarction in man. American Heart Journal. 91(6). 705–711. 18 indexed citations
18.
Rydén, Lars, et al.. (1975). Blood levels of lidocaine after various infusion rates in patients with acute myocardial infarction. American Heart Journal. 89(4). 470–473. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Greetje de Vries Breakdown of academic impact, for papers by I. Kardasz Breakdown of academic impact, for papers by C. Thuillez Breakdown of academic impact, for papers by M.L. Muiesan Breakdown of academic impact, for papers by Wassim Choucair Breakdown of academic impact, for papers by Francesca Palano Breakdown of academic impact, for papers by W. Kamke Breakdown of academic impact, for papers by Pieralberto Visentin Breakdown of academic impact, for papers by İstemi Nalbantgil Breakdown of academic impact, for papers by E. Laufer
Rankless by CCL
2026